Abnormalities in neural progenitor cells in a dog model of lysosomal storage disease

被引:16
|
作者
Walton, Raquel M.
Wolfe, John H.
机构
[1] Univ Penn, Sch Vet Med, Dept Pathol, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Stokes Res Inst, Philadelphia, PA 19104 USA
关键词
canine; cerebellum; mucopolysaccharidosis VII; neural progenitor cells; olfactory bulb; subventricular zone;
D O I
10.1097/nen.0b013e31812571c8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Lysosomal storage disorders constitute a large group of genetic diseases, many of which are characterized by mental retardation and other neurologic symptoms. The mechanisms of neural dysfunction remain poorly understood. Because neural progenitor cells (NPCs) are fundamentally important to normal brain development and function, we investigated NPC properties in a canine model of mucopolysaccharidosis VII (NIPS VII). MPS VII is a lysosomal storage disorder characterized by defects in the catabolism of glycosaminoglycans. NPCs were isolated from the olfactory bulb, cerebellum, and striatal subventricular zone of normal and MPS VII (beta-glucuronidase-deficient) postnatal dog brains. Canine NPCs (cNPCs) from normal and MPS VII brains had similar growth curves, but cerebellar-derived cNPCs grew significantly slower than those derived from other regions. In differentiation assays, MPS VII cNPCs from the striatal subventricular zone and cerebellum generated fewer mature neuronal and/or glial cells than normal, and MPS VII olfactory bulb-derived cNPCs retained significantly more phenotypically immature cells. These differences were only present at the earliest time point after isolation; at later passages, there were no differences attributable to genotype. The data suggest that MPS VII cNPCs respond differently to developmental cues in vivo, probably because of the diseased neural microenvironment rather than intrinsic cellular deficits.
引用
收藏
页码:760 / 769
页数:10
相关论文
共 50 条
  • [1] BEHAVIORAL ABNORMALITIES IN A MURINE MODEL OF A HUMAN LYSOSOMAL STORAGE DISEASE
    CHANG, PL
    LAMBERT, DT
    PISA, MA
    NEUROREPORT, 1993, 4 (05) : 507 - 510
  • [2] Gene-modified neural progenitor cells for the treatment of neuropathic lysosomal storage diseases
    Mandolfo, Oriana
    Bigger, Brian W.
    NEURAL REGENERATION RESEARCH, 2023, 18 (09) : 1954 - 1955
  • [3] Gene-modified neural progenitor cells for the treatment of neuropathic lysosomal storage diseases
    Oriana Mandolfo
    Brian W.Bigger
    Neural Regeneration Research, 2023, 18 (09) : 1954 - 1955
  • [4] Xenotransplantation of iPSC Derived Neural Stem Cells from a Patient with Lysosomal Storage Disease
    Griffin, Tagan A.
    Wolfe, John H.
    MOLECULAR THERAPY, 2012, 20 : S18 - S18
  • [5] Skeletal Abnormalities in Lysosomal Storage Diseases
    Stevenson, David A.
    Steiner, Robert D.
    PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2013, 10 : 406 - 416
  • [6] Lysosomal Abnormalities in Cardiovascular Disease
    Chi, Congwu
    Riching, Andrew S.
    Song, Kunhua
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [7] Cysteine proteinase inhibitors as a model of lysosomal storage disease
    Korolenko, TA
    Svechnikova, IG
    Arkhipov, SA
    PROTEOLYSIS IN CELL FUNCTIONS, 1997, 13 : 540 - 544
  • [8] β-Mannosidosis mice:: a model for the human lysosomal storage disease
    Zhu, M
    Lovell, KL
    Patterson, JS
    Saunders, TL
    Hughes, ED
    Friderici, KH
    HUMAN MOLECULAR GENETICS, 2006, 15 (03) : 493 - 500
  • [9] MODEL FOR A LYSOSOMAL STORAGE DISEASE AND A POSSIBLE METHOD OF THERAPY
    COLLEY, CM
    RYMAN, BE
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1974, 2 (05) : 871 - 872
  • [10] Lysosomal Storage Disease
    Khatiwada, B.
    Pokharel, A.
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2009, 48 (03) : 242 - 245